 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE-- DNA--Twist Bioscience Corporation NASDAQ: TWST, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the fourth quarter and full year fiscal 2020 ended September 30, 2020. We ended our fiscal year with record revenue and orders against the backdrop of a global pandemic and significant uncertainty, said Emily M. Leproust, Ph.D 